**Sir,**

The paper by [Yoshikawa *et al* (2008)](#bib6){ref-type="other"} is of considerable interest to our group. The authors assessed the expression of Gli-1 in the residual squamous cell carcinoma of the oesophagus in the resected specimens of the patients treated with preoperative chemoradiation. The expression of Gli-1 correlated with poor prognosis. When employing the strategy of preoperative chemoradiation in oesophageal carcinoma, the prognosis of the patients can be determined by assessing the degree of residual cancer ([Chirieac *et al*, 2005](#bib1){ref-type="other"}; [Wu *et al*, 2007](#bib5){ref-type="other"}). In addition, the residual cancer correlates with metastatic potential ([Rohatgi *et al*, 2005](#bib2){ref-type="other"}). It would be of interest to document that Gli-1 expression has an independent prognostic value. The authors did not report a multivariate analysis. Our group first documented the expression and temporal kinetics of sonic hedgehog ligand and Gli-1 protein expression in a xenograft model using oesophageal cancer cell lines ([Sims-Mourtada *et al*, 2006](#bib4){ref-type="other"}). Both biomarkers correlated with chemoradiation resistance and dynamics of tumour repopulation after chemoradiation ([Sims-Mourtada *et al*, 2006](#bib4){ref-type="other"}). Furthermore, our group documented that sonic hedgehog signalling mediates chemotherapy resistance through multiple drug transporter mechanisms and that this resistance can be overcome by inhibitors of the sonic hedgehog pathway ([Sims-Mourtada *et al*, 2007](#bib3){ref-type="other"}). Unfortunately, [Yoshikawa *et al* (2008)](#bib6){ref-type="other"} have neglected to discuss these two publications.
